Cargando…
Attenuation of Metabolic Syndrome by EPA/DHA Ethyl Esters in Testosterone-Deficient Obese Rats
Inducing testosterone deficiency, as the standard treatment of prostate cancer, may cause metabolic disorders including insulin resistance, dyslipidemia, central obesity, cardiovascular diseases, and type 2 diabetes. This study measured responses to testosterone deficiency in high-carbohydrate, high...
Autores principales: | Bhandarkar, Nikhil S., Kumar, Senthil Arun, Martin, Jarad, Brown, Lindsay, Panchal, Sunil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024942/ https://www.ncbi.nlm.nih.gov/pubmed/29794984 http://dx.doi.org/10.3390/md16060182 |
Ejemplares similares
-
Addressing the Insufficient Availability of EPA and DHA to Meet Current and Future Nutritional Demands
por: Panchal, Sunil K., et al.
Publicado: (2021) -
Determination and evaluation of EPA and DHA ethyl esters in fish oils using the TMAH transesterification method
por: Wu, Pai-Wen, et al.
Publicado: (2023) -
Switching from EPA + DHA (Omega-3-acid Ethyl Esters) to High-Purity EPA (Icosapent Ethyl) in a Statin-Treated Patient with Persistent Dyslipidemia and High Cardiovascular Risk: A Case Study
por: Crandell, James R.
Publicado: (2016) -
Marine Cryptophytes Are Great Sources of EPA and DHA
por: Peltomaa, Elina, et al.
Publicado: (2017) -
Are EPA and DHA Derivatives Involved in IBD Remission?
por: Kikut, Justyna, et al.
Publicado: (2022)